Medpace Holdings, Inc.

Halal Rating :
See Details
Last Price $423.94 Last updated:
Market Cap $12.76b
7D Change -4.37%
1 Year Change -4.37%

Company Overview

  • Commercial Services
  • Miscellaneous Commercial Services
Exchange NASDAQ
Next Earnings Date Feb. 12, 2024

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $511.04m $448.91m - $4.12m 0.00% 0.92%
Dec. 31, 2023 $496.5m $452.99m - $1.84m 0.00% 0.41%
Sept. 30, 2023 $492.5m $443.32m - $105000.0 0.00% 0.02%

Company Impact

Help us evaluate Medpace Holdings, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates